Why a New Inhalable Lung Cancer Treatment Is So Promising Why a New Inhalable Lung Cancer Treatment Is So Promising
Study showed that exosomes (tiny spheres released by cells) can deliver potent immunotherapy to lung cancer tumors.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 19, 2024 Category: Consumer Health News Tags: Hematology-Oncology Source Type: news
This Mutation Likely Saved a Colon Cancer Patient's Life
His tumor had a specific genetic makeup known as mismatch repair-deficient, present in 5% to 10% of all rectal cancer patients, meaning he might qualify for a cutting-edge immunotherapy. (Source: WebMD Health)
Source: WebMD Health - March 18, 2024 Category: Consumer Health News Source Type: news
Bringing Immunotherapy Straight to the Source
Engineered natural killer cells track down cancer cells in the bone marrow. (Source: The Scientist)
Source: The Scientist - March 14, 2024 Category: Science Tags: News News & Opinion Source Type: news
No Benefit to Adding Chemotherapy in Older Adults With NSCLC No Benefit to Adding Chemotherapy in Older Adults With NSCLC
Adding chemotherapy to immunotherapy increased the adverse event burden without improving survival outcomes compared with immunotherapy alone in older adults with NSCLC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 14, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news
Novartis acquires Boston immunotherapy startup
Novartis has made a habit of acquiring IFM Therapeutics subsidiaries to create new treatments for cancer, auto-immunity, and inflammatory disorders. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 13, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news
Sublingual Immunotherapy Safe, Effective for Older Kids Sublingual Immunotherapy Safe, Effective for Older Kids
A Canadian study suggested that SLIT is safe and effective in older children and teens with multiple food allergies who are at a high risk for severe reaction.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 13, 2024 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology Source Type: news
Why You Suddenly Have Allergies
When Dr. Gailen Marshall was training to become a physician, he was taught that allergies were a kid thing. “Back in the day, the allergist’s office was full of children,” says Marshall, who is the president of the American College of Allergy, Asthma, and Immunology. “If you ever thought about doing allergy testing or allergy shots in someone older than 40, that’s because you were just a money-grubbing doctor.”
A lot has changed since then. In 2021, about a quarter of U.S. adults reported seasonal allergies, compared to 19% of children.
[time-brightcove not-tgx=”true”]
...
Source: TIME: Health - March 12, 2024 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate Source Type: news
Tapping Into Immunotherapy’s Potential to Help More People
Discover what researchers have learned about varying immunotherapy response rates between patients with the same cancer types. (Source: The Scientist)
Source: The Scientist - March 8, 2024 Category: Science Tags: Sponsored Webinars Source Type: news
Q & A: Immunotherapy in Renal Cell Carcinoma (RCC) Q & A: Immunotherapy in Renal Cell Carcinoma (RCC)
A collaboration and conversation between Medscape and Dr Karl D ' Silva on the impact of immunotherapy in renal cell carcinoma.Medscape (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - March 8, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Guideline Issued for Management of Inhalant Allergies With Immunotherapy
THURSDAY, March 7, 2024 -- In a clinical practice guideline (CPG) issued by the American Academy of Otolaryngology-Head and Neck Surgery Foundation and published online in the March issue of Otolaryngology–Head and Neck Surgery,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 7, 2024 Category: Pharmaceuticals Source Type: news
First-Line Immunotherapy Alone Sufficient for Older NSCLC Patients, Study Suggests
(MedPage Today) -- Adding an immune checkpoint inhibitor (ICI) to chemotherapy for older patients with previously untreated advanced non-small cell lung cancer (NSCLC) provided no survival advantage compared with ICI therapy alone, according to... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - March 7, 2024 Category: Hematology Source Type: news
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production Being Developed for GeoVax MVA-Based Vaccines ATLANTA, GA, March 06, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. GOVX, a biotechnology company developing immunotherapies and vaccines against cancers and infectious…#vaccines #atlanta #geovaxlabs #govx #cef #mva #geocm04s1 #cdmoableurope #oxfordbiomedica #daviddodd (Source: Reuters: Health)
Source: Reuters: Health - March 6, 2024 Category: Consumer Health News Source Type: news
Navigating Cancer Care in RCC: Reflections and Advancements Navigating Cancer Care in RCC: Reflections and Advancements
Dr Jose A. Karam reflects on navigating dual kidney tumors in his early career, highlighting advancements in kidney cancer care from genetic counseling to immunotherapy.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 5, 2024 Category: Consumer Health News Tags: None MDAngle Source Type: news
‘I feel like myself again’: UCLA clinical trial offers hope for lymphoma patients
In June 2018, actor Hirotaka Matsunaga was supposed to be two weeks away from opening night of “The Swords of Sorrow: BURAI II,” a play set in 1800s Japan. The 39-year-old had been cast as the lead. It was the big break he had been working toward since he moved to the U.S. from Japan more than 20 years ago to pursue his dreams.But his cancer diagnosis and an unsuccessful course of chemotherapy had shut down the play.“Around November 2017, I had acute pain in my stomach for weeks, and it got so bad that it became difficult to eat,” Matsunaga said.After a particularly agonizing dinner, he checked himself into a hosp...
Source: UCLA Newsroom: Health Sciences - March 5, 2024 Category: Universities & Medical Training Source Type: news
Drug that could slow womb cancer to be rolled out by NHS in England
Dostarlimab or Jemperli, an immunotherapy used alongside chemotherapy, could extend life expectancyA drug that could improve the quality of life of hundreds of women with womb cancer will be rolled out on the NHS across England from Tuesday.Dostarlimab, also known as Jemperli, is an immunotherapy that works by attracting specific proteins on the surface of cancer cells to help the immune system attack them.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 5, 2024 Category: Science Authors: Tobi Thomas Tags: Cancer Women's health UK news England Medical research NHS Source Type: news